|
Erythromycin
|
D004917 |
[A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
] |
|
Erythromycin Estolate
|
D004918 |
[A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
] |
|
Erythromycin Ethylsuccinate
|
D015643 |
[A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
] |
|
Erythroplasia
|
D004919 |
[A condition of the mucous membrane characterized by erythematous papular lesions.
] |
|
Erythropoiesis
|
D004920 |
[The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.
] |
|
Erythropoietin
|
D004921 |
[Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
] |
|
Erythrosine
|
D004923 |
[A tetraiodofluorescein used as a red coloring in some foods (cherries, fish), as a disclosure of DENTAL PLAQUE, and as a stain of some cell types. It has structural similarity to THYROXINE.
] |
|
Erythrovirus
|
D019218 |
[A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, and containing the type species PARVOVIRUS B19, HUMAN.
, Species of Erythrovirus affecting cynomolgus monkeys and highly similar to PARVOVIRUS B19, HUMAN.
] |
|
Erythroxylaceae
|
D030921 |
[A plant family of the order Linales, subclass Rosidae, class Magnoliopsida best known for the coca plant.
] |
|
Escape Reaction
|
D004924 |
[Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy.
] |
|
Escherichia
|
D004925 |
[A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.
] |
|
Escherichia coli
|
D004926 |
[A pathotype (virotype) of E. coli capable of invading and multiplying in the intestinal epithelial cells of the distal large intestines in humans.
, A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
, A pathotype (virotype) of E. coli characterized by a distinct aggregative adherence pattern to HEp-2 cells.
, A pathotype (virotype) of E. coli characterized by the presence of the diffuse adherence pattern to HEp-2 cells.
] |
|
Escherichia coli Infections
|
D004927 |
[Infections with bacteria of the species ESCHERICHIA COLI.
] |
|
Escherichia coli K12
|
D048168 |
[A species of gram-negative, rod-shaped bacteria belonging to the K serogroup of ESCHERICHIA COLI. It lives as a harmless inhabitant of the human LARGE INTESTINE and is widely used in medical and GENETIC RESEARCH.
] |
|
Escherichia coli O104
|
D000069981 |
[An enterohemorrhagic Escherichia coli of the O subfamily that can cause severe FOODBORNE DISEASE. The H4 serotype strain produces SHIGA TOXINS and has been linked to human disease outbreaks, including some cases of HEMOLYTIC-UREMIC SYNDROME, resulting from contamination of foods by feces containing E. coli O104.
] |
|
Escherichia coli O157
|
D019453 |
[A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. A strain from this serogroup, serotype H7, which produces SHIGA TOXINS, has been linked to human disease outbreaks resulting from contamination of foods by E. coli O157 from bovine origin.
] |
|
Escherichia coli Proteins
|
D029968 |
[Proteins obtained from ESCHERICHIA COLI.
] |
|
Escherichia coli Vaccines
|
D022361 |
[Vaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.
] |
|
Eschscholzia
|
D031675 |
[A plant genus of the family PAPAVERACEAE that contains benzo[c]phenanthridine alkaloids.
] |
|
Escin
|
D004928 |
[Pentacyclic triterpene saponins, biosynthesized from protoaescigenin and barringtogenol, occurring in the seeds of AESCULUS. It inhibits edema formation and decreases vascular fragility.
] |
